Arcus Biosciences Files 8-K
Ticker: RCUS · Form: 8-K · Filed: Apr 20, 2026 · CIK: 0001724521
| Field | Detail |
|---|---|
| Company | Arcus Biosciences, Inc. (RCUS) |
| Form Type | 8-K |
| Filed Date | Apr 20, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, sec-filing
TL;DR
Arcus filed an 8-K, no juicy details yet.
AI Summary
Arcus Biosciences, Inc. filed an 8-K on April 20, 2026, reporting other events. The filing does not contain specific financial figures or material events beyond the reporting of an event.
Why It Matters
This filing indicates Arcus Biosciences has reported an event to the SEC, but the nature and impact of this event are not detailed in the provided information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and does not disclose specific material information that would immediately impact risk.
Key Players & Entities
- Arcus Biosciences, Inc. (company) — Filer of the 8-K
- 0001724521 (company) — CIK number for Arcus Biosciences, Inc.
- 2026-04-20 (date) — Filing date of the 8-K
FAQ
What specific event is Arcus Biosciences reporting in this 8-K filing?
The filing is an 8-K for 'Other Events' (Item 8.01), but the specific event is not detailed in the provided text.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 20, 2026, at 07:56:39.
What is the CIK number for Arcus Biosciences, Inc.?
The CIK number for Arcus Biosciences, Inc. is 0001724521.
What is the business address of Arcus Biosciences, Inc.?
The business address is 3928 POINT EDEN WAY, HAYWARD, CA 94545.
What is the SIC code for Arcus Biosciences, Inc.?
The SIC code is 2834 for Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 20, 2026 regarding Arcus Biosciences, Inc. (RCUS).